Rising Prevalence of Respiratory Disorders Bolsters Growth of Capnography Equipment Market in North America
Chronic respiratory diseases are prevalent noncommunicable diseases worldwide due to the commonness of noxious environmental, occupational, and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). As Per the Office of Disease Prevention and Health Promotion, ~14.8 million adults in the US were diagnosed with COPD in 2020. According to the estimates by the Centers for Disease Control and Prevention (CDC), ~24.8 million people in the US were suffering from asthma in 2018. Moreover, in 2017, the country recorded an estimated 1.6 million emergency department (ED) visits and 183,000 hospitalizations due to asthma. Capnography is a method of monitoring the concentration or partial pressure of carbon dioxide (CO2 ). The continuous measurement of human respiratory CO2 by using a capnograph provides valuable information about cardiopulmonary resuscitation, endotracheal tube placement, pulmonary embolism, and procedural sedation. The equipment is also used to obtain information on the effect of air pollution on cardiopulmonary characteristics and the effectiveness of a treatment for a patient with respiratory distress. Changes in the shape of the capnogram are used to diagnose respiratory disease conditions. Changes in end-tidal CO2 (EtCO2)—i.e., the maximum CO2 concentration at the end of each tidal breath—can be used to assess disease severity and response to treatment. Therefore, the prevalence of respiratory disorders drives the growth of the capnography equipment market in North America.
Market Overview
The North America capnography equipment market is segmented into the US, Canada, and Mexico. The market growth in the region is attributed to the growing prevalence of respiratory diseases due to unhealthy lifestyles, rising technological advancements in capnography devices, and increasing government initiatives. According to CDC, cigarette smoking in the US contributes to 80–90% of lung cancer deaths. Also, CDC estimated that about 13 of every 100 adults (12.5%) in the US aged 18 years and above smoked cigarettes, which indicates that 16 million people of this age group suffer from smoking-related disease. Rising respiratory disorders propel the need for early detection. According to the American Cancer Society, second-hand smoke leads to about 7,000 lung cancer deaths in the US each year. Furthermore, about 25 million population in the US is suffering from asthma, according to The American College of Allergy, Asthma & Immunology. The American Heart Association (AHA) recommends the use of capnography monitoring to help physicians monitor the chest compressions quality to confirm endotracheal tube placement and use it as an early indicator of the return of spontaneous circulation. The Association for Radiologic and Imaging Nursing (ARIN) supports the use of capnography for patients with moderate sedation or analgesia during imaging environment procedures. Thus, increasing initiatives by guiding bodies promote the growth of the capnography equipment market in North America.
Strategic insights for the North America Capnography Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 201.81 Million |
Market Size by 2028 | US$ 302.81 Million |
Global CAGR (2022 - 2028) | 7.0% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Capnography Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
North America Capnography Equipment Market Segmentation
The North America capnography equipment market is segmented on the basis of product type, technology, application, end user, and country. Based on product type, the market is bifurcated into capnometers and capnography accessories & disposables. The capnography accessories & disposables segment held a larger market share in 2022.
Based on technology, the North America capnography equipment market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. The mainstream capnography segment held the largest market share in 2022. Based on application, the North America capnography equipment market is segmented into cardiac care, trauma and emergency care, procedural sedation, respiratory monitoring, and others. The cardiac care segment accounted for the largest market share in 2022. Based on end user, the North America capnography equipment market is segmented into hospitals, ambulatory surgery center, home care settings, and others. The hospitals segment held the largest market share in 2022. Based on country, the North America capnography equipment market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022. BD, Dragerwerk AG & Co. KGaA, General Electric Company, Hill Rom Holding Inc. (Baxter), ICU Medical Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, and SCHILLER Americas Inc. are among the leading companies operating in the capnography equipment market in North America.
The North America Capnography Equipment Market is valued at US$ 201.81 Million in 2022, it is projected to reach US$ 302.81 Million by 2028.
As per our report North America Capnography Equipment Market, the market size is valued at US$ 201.81 Million in 2022, projecting it to reach US$ 302.81 Million by 2028. This translates to a CAGR of approximately 7.0% during the forecast period.
The North America Capnography Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Capnography Equipment Market report:
The North America Capnography Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Capnography Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Capnography Equipment Market value chain can benefit from the information contained in a comprehensive market report.